Barbara Polski-Seitz
Nice, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications
Diagnostic Value of the Kappa Free Light Chain Index to Distinguish MOGAD, NMOSD, and MS.
Journal: Neurology
Published: April 01, 2026
Immunogenicity of PCV13 during Hospitalization soon after infection resolution: Vaccis study.
Journal: NPJ vaccines
Published: December 29, 2025
Early-Stage B-cells Predict Relapse After Rituximab Treatment in Patients With Membranous Nephropathy.
Journal: Kidney international reports
Published: September 25, 2025
Anti-rituximab antibodies in autoimmune diseases and hematologic malignancies: An update
Journal: La Revue de medecine interne
Published: September 03, 2025
Chronic air pollution exposure is associated with lower chance of live birth after frozen embryo transfer.
Journal: Reproductive biomedicine online
Published: August 27, 2025
Artificial intelligence-based personalised rituximab treatment protocol in membranous nephropathy (iRITUX): protocol for a multicentre randomised control trial.
Journal: BMJ open
Published: April 03, 2025
Anti-Rituximab Antibodies Occurrence and Clinical Outcomes in Patients With Primary Membranous Nephropathy.
Journal: Kidney international reports
Published: March 01, 2025
Relevance of Kappa and Lambda Free Light Chains in Autoimmune Astrocytopathy Associated With Anti-GFAP Antibodies.
Journal: Annals of clinical and translational neurology
Published: February 25, 2025
Artificial intelligence to guide rituximab therapy in patients with phospholipase A2 receptor-associated membranous nephropathy.
Journal: Clinical kidney journal
Published: November 16, 2024
Last Updated: 09/26/2026